tibulizumab

Ligand id: 10350

Name: tibulizumab

No information available.
Summary of Clinical Use
Tibulizumab (LY3090106) is a Phase 1 clinical candidate for Sjögren's syndrome and rheumatoid arthritis. Click here to link to ClinicalTrials.gov's full list of tibulizumab trials.